Display Settings:

Format

Send to:

Choose Destination

    Nat Genet. 1994 May;7(1):98-102.

    Mutations of the E-cadherin gene in human gynecologic cancers.

    Risinger JI, Berchuck A, Kohler MF, Boyd J.

    Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Triangle Park, North Carolina 27709.

    Expression of the E-cadherin cell adhesion molecule is reduced in several types of human carcinomas, and the protein serves as an invasion suppressor in vitro. To determine if mutations of the E-cadherin gene (on chromosome 16q22) contribute to epithelial tumorigenesis, 135 carcinomas of the endometrium and ovary were examined for alterations in the E-cadherin coding region. Four mutations were identified: one somatic nonsense and one somatic missense mutation, both with retention of the wild-type alleles, and two missense mutations with somatic loss of heterozygosity in the tumour tissue. These data support the classification of E-cadherin as a human tumour suppressor gene.

    PMID: 8075649 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read